Spots Global Cancer Trial Database for gp96
Every month we try and update this database with for gp96 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer | NCT01799161 | Non-Small Cell ... Non-small-cell ... Lung Cancer NSCLC | gp96-Ig Vaccine Theophylline Oxygen Immunologic Eva... | 18 Years - | University of Miami | |
| A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer | NCT02439450 | Non-small Cell ... | Viagenpumatucel... Nivolumab Pembrolizumab Pemetrexed | 18 Years - | Heat Biologics | |
| Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 | NCT02122822 | Glioma | gp96 | 18 Years - 75 Years | Cure&Sure Biotech Co., LTD | |
| Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 | NCT02122822 | Glioma | gp96 | 18 Years - 75 Years | Cure&Sure Biotech Co., LTD | |
| GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer | NCT04206254 | Liver Cancer | gp96 | 18 Years - 75 Years | Cure&Sure Biotech Co., LTD | |
| A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer | NCT02439450 | Non-small Cell ... | Viagenpumatucel... Nivolumab Pembrolizumab Pemetrexed | 18 Years - | Heat Biologics | |
| A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 | NCT03650257 | Glioma of Brain | gp96 Temozolomide radiotherapy | 18 Years - 75 Years | Cure&Sure Biotech Co., LTD | |
| Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 | NCT02122822 | Glioma | gp96 | 18 Years - 75 Years | Cure&Sure Biotech Co., LTD | |
| A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT | NCT02010203 | Bladder Cancer | HS-410 Placebo BCG | 18 Years - | Heat Biologics | |
| A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 | NCT03650257 | Glioma of Brain | gp96 Temozolomide radiotherapy | 18 Years - 75 Years | Cure&Sure Biotech Co., LTD | |
| A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors | NCT04116710 | Advanced Solid ... | HS-110 (viagenp... HS-130 | 18 Years - | Heat Biologics | |
| GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer | NCT04206254 | Liver Cancer | gp96 | 18 Years - 75 Years | Cure&Sure Biotech Co., LTD | |
| A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT | NCT02010203 | Bladder Cancer | HS-410 Placebo BCG | 18 Years - | Heat Biologics | |
| A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer | NCT02117024 | Non Small Cell ... | Viagenpumatucel... Metronomic Cycl... Physician's Cho... | 18 Years - | Heat Biologics | |
| A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors | NCT04116710 | Advanced Solid ... | HS-110 (viagenp... HS-130 | 18 Years - | Heat Biologics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
